Alembic Global Holding SA gets USFDA nod for pulmonary arterial hypertension treatment injection
Posted by
www.biotecnika.org
Drug firm Alembic Pharmaceuticals on Friday said its arm, Alembic
Global Holding SA, has received approval from the US health regulator
for its generic Treprostinil injection used for the treatment of
pulmonary arterial hypertension.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-global-holding-sa-gets-usfda-nod-for-pulmonary-arterial-hypertension-treatment-injection/articleshow/80879959.cms
Subscribe to:
Post Comments (Atom)
Post a Comment